Dr.
Julio Martín-García
Drexel
University, USA
Email: julio.martin-garcia@drexelmed.edu
Qualifications
1997 Ph.D., Universidad Autónoma
of Madrid, Spain
1990 B.Sc., Universidad Complutense of Madrid,
Spain
Publications
(Selected)
-
Navas
S, Martín J, Quiroga JA, Castillo I, Carreño V. Genetic diversity and tissue
compartmentalization of the hepatitis C virus genome in blood mononuclear
cells, liver, and serum from chronic hepatitis C patients. Journal of Virology
1998; 72: 1640-1646.
-
Martín
J, Navas S, Quiroga JA, Colucci G, Pardo M, Carreño V. Quantitation of
hepatitis C virus (HCV) RNA in liver and peripheral blood mononuclear cells
from patients with chronic HCV infection. Journal of Medical Virology 1998; 54:
265-270.
-
Martín
J, Navas S, Quiroga JA, Pardo M, Carreño V. Effects of the ribavirin-interferon
a combination on cultured peripheral blood mononuclear cells from chronic
hepatitis C patients. Cytokine 1998; 10: 635-644.
-
Martín
J, Navas S, Fernández M, Rico M, Pardo M, Quiroga JA, Zahm F, Carreño V.
Antiviral effect of amantadine and interferon a-2a against hepatitis C virus on
peripheral blood mononuclear cells from chronic hepatitis C patients. Antiviral
Research 1999; 42: 59-70.
-
Shieh
JTC, Martín J, Baltuch G, Malim MH, González-Scarano F. Determinants of
syncytium formation in microglia by human immunodeficiency virus type 1: role
of the V1/V2 domains. Journal of Virology 2000; 74: 693-701.
-
Albright
AV, Martín J, O’Connor M, González-Scarano F. Interactions between HIV-1 gp120,
chemokines, and cultured adult microglial cells. Journal of Neurovirology 2001;
7: 196-207.
-
Martín
J, LaBranche CC, González-Scarano F. Differential CD4/CCR5 utilization, gp120
conformation, and neutralization sensitivity between envelopes from a
microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Journal of Virology 2001; 75: 3568-3580.
-
Martín-García
J, Kolson DL, González-Scarano F. Chemokine receptors in the brain: their role
in HIV infection and pathogenesis. AIDS 2002; 16: 1709-1730.
-
González-Scarano
F, Martín-García J. The neuropathogenesis of AIDS. Nature Reviews Immunology
2005; 5: 69-81.
-
Martín-García
J, Cocklin S, Chaiken IM, González-Scarano F. Interaction with CD4 and
antibodies to CD4-induced epitopes of the envelope gp120 from a
microglia-adapted human immunodeficiency virus type 1 isolate. Journal of
Virology 2005, 79: 6703-6713.
-
Plassmeyer
ML, Soldan SS, Stachelek KM, Martín-García J, González-Scarano F. California
serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent
cell fusion and entry. Virology 2005, 338: 121-132.
-
Martín-García
J, Cao W, Varela-Rohena A, Plassmeyer ML, González-Scarano F. HIV-1 tropism for
the central nervous system: brain-derived envelope glycoproteins with lower
CD4-dependence and reduced sensitivity to a fusion inhibitor. Virology 2006,
346: 169-179.
-
Chen
MF, Westmoreland S, Ryzhova EV, Martín-García J, Soldan SS, Lackner A,
González-Scarano F. Simian immunodeficiency virus envelope compartmentalizes in
brain regions independent of neuropathology. Journal of Neurovirology 2006, 12:
73-89.
-
Plassmeyer
ML, Soldan SS, Stachelek KM, Roth SM, Martín-García J, González-Scarano F.
Mutagenesis of the La Crosse virus glycoprotein supports a role for Gc
(1066-1087) as the fusion peptide. Virology 2007, 358: 273-282.
-
Cocklin
S, Gopi H, Querido B, Nimmagadda M, Kuriakose S, Cicala C, Ajith S, Baxter S,
Arthos J, Martín-García J, Chaiken IM. Broad-spectrum anti-HIV potential of a
peptide HIV-1 entry inhibitor. Journal of Virology 2007, 81: 3645-3648.
-
Rossi
F, Querido B, Nimmagadda D, Cocklin S, Navas-Martín S, Martín-García J. The
V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines
macrophage tropism, low CD4 dependence, increased fusogenicity and altered
sensitivity to entry inhibitors. Retrovirology 2008, 5:89.
-
Rajagopalan
N, Suchitra JB, Shet A, Khan ZK, Martín-García J, Nonnemacher MR, Jacobson JM,
Wigdahl B. Mortality among HIV-infected patients in resource limited
settings: A case controlled analysis of inpatients at a community care center. American
Journal of Infectious Diseases 2009, 5: 226-231.
-
Li
L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, Flaig K,
Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martín-García J, Moldover B,
Servance L, Downie D, Lewis S, Jacobson JM, Kolson D, Wigdahl B. Development of
co-selected single nucleotide polymorphisms in the viral promoter precedes the
onset of human immunodeficiency virus type 1-associated neurocognitive
impairment. Journal of Neurovirology 2011; 17:92-109.